1,412 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

GS70

GSK
UK£36.200%6.5%UK£62.7bUK£46.59PE15.5xE14.3%3.8%

MRK

Merck KGaA
€160.551.9%1.5%€69.8b€187.18PE26.6xE11.9%1.4%

MRKC

Merck KGaA
€31.60-3.7%3.3%€69.8b€36.84PE26.6xE11.9%1.4%

MRK

Merck KGaA
€161.052.1%1.7%€69.8b€187.76PE26.6xE11.9%1.4%

MRKC

Merck KGaA
€30.804.8%n/a€69.8b€36.03PE26.5xE11.9%1.4%

D4S

Daiichi Sankyo Company
JP¥28.79-6.6%13.2%JP¥9.3tJP¥38.69PE40.4xE20.0%1.2%

TKD

Takeda Pharmaceutical
JP¥25.45-3.7%-11.6%JP¥6.6tJP¥29.15PE44xE22.4%4.7%

TKDA

Takeda Pharmaceutical
JP¥12.90-1.5%-11.0%JP¥6.6tJP¥14.78PE44xE22.4%4.7%

LO3A

Lonza Group
CHF 57.500%34.3%CHF 38.9bCHF 66.66PE67.9xE24.7%0.7%

SGT

Seagen
US$208.603.4%74.0%US$43.2bUS$208.75PS18.8xE71.8%n/a

QTS

IQVIA Holdings
US$210.20-2.8%13.4%US$42.8bUS$247.79PE30.1xE13.2%0%

TKDA

Takeda Pharmaceutical
JP¥13.500%n/aJP¥6.6tJP¥15.21PE46.1xE20.0%4.6%

AG8

Agilent Technologies
US$134.006.2%25.2%US$42.2bUS$133.50PE30.1xE3.7%0.6%

QTS

IQVIA Holdings
US$231.450%-1.5%US$41.7bUS$265.93PE35.2xE16.0%0%

DUL

Alnylam Pharmaceuticals
US$248.000.5%51.2%US$35.2bUS$257.92PS15.1xE65.2%n/a

UNC

UCB
€162.451.7%108.2%€30.6b€166.12PE127.5xE35.6%0.8%

UNC0

UCB
€81.003.2%113.2%€30.6b€82.83PE127.5xE35.6%0.8%

BAYA

Bayer
€7.407.2%-33.9%€29.9b€8.34PB0.8xE37.3%0.4%

BAYN

Bayer
€30.396.0%-33.1%€29.9b€34.24PB0.8xE37.3%0.4%

BAYN

Bayer
€30.135.5%-33.7%€29.9b€33.95PB0.8xE37.3%0.4%

1AEA

argenx
€360.000%-26.2%€28.8b€381.55PS19.3xE58.4%n/a

1AEA

argenx
€464.00-2.1%1.8%€28.6b€495.07PS19.3xE58.4%n/a

1AE

argenx
€473.60-0.3%4.3%€28.6b€505.31PS19.3xE58.4%n/a

MTO

Mettler-Toledo International
US$1,332.003.6%26.4%US$31.6bUS$1,244.71PE39.9xE8.4%n/a
Page 3 of 59
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.